Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was Performed
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorUniversitaire Ziekenhuizen KU Leuven
About this trial
The purpose of this study is to register the follow-up data of patients who, because of a peritoneal surface malignancy, will undergo cytoreductive surgery and HIPEC.
Eligibility criteria
Qualifiers
Patients with peritoneal carcinomatosis of colorectal origin, patients with pseudomyxoma peritonei (type DPAM or PMCA) and patients with peritoneal mesothelioma who are planned to undergo cytoreductive surgery and HIPEC because of a peritoneal surface malignancy
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
125 Participants
are grouped into 1 trial groupLocations
1University Clinics Gasthuisberg3000, LeuvenFlemish Brabant, Belgium
Sponsors and collaborators
Universitaire Ziekenhuizen KU Leuven
Lead sponsor
Source ClinicalTrials.gov